IP Library Granted Patent US 8,906,349
Granted Patent B2
US 8,906,349 · App. 13/387,780 · Granted Dec 9, 2014

Oral care composition

Inventors: Lyndsay Schaeffer-Korbylo (Flemington, NJ); Andre Michelle Morgan (Robbinsville, NJ); Davide Miksa (Doylestown, PA); Laurence Du-Thumm (Princeton, NJ); Michael Prencipe (Princeton Junction, NJ); Evangelia S. Arvanitidou (Princeton, NJ); Gregory Szewczyk (Flemington, NJ)
Assignee: Colgate-Palmolive Company
A61K8/342A01N49/00A61K8/35A61Q11/00A61K8/347
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,906,349
App. No.
13/387,780
Granted
Dec 9, 2014
Kind
B2
Abstract

Disclosed are oral care compositions and the use of such oral care compositions for treating conditions caused by biofilm formation. Also disclosed are methods for inhibiting biofilm formation and/or degrading biofilm. The oral care composition includes a sesquiterpenoid and an antimicrobial agent, in which the sesquiterpenoid and the antimicrobial agent are present in an amount effective to inhibit and/or degrade a biofilm in the oral cavity.

Claims (18)

1. An oral care composition comprising a sesquiterpenoid and an antimicrobial agent, wherein the sesquiterpenoid and the antimicrobial agent are present in an amount effective to inhibit and/or degrade a biofilm in the oral cavity, wherein the sesquiterpenoid is bisabolol; and

the antimicrobial agent is triclosan;

wherein the bisabolol is present in the composition at a concentration of 0.025 to 0.075% w/w; and

wherein the sesquiterpenoid has a BEC 50 in the presence of the antimicrobial agent of 25% or less compared to the BEC 50 of the sesquiterpenoid in the absence of the antimicrobial agent.

2. The oral care composition according to claim 1 wherein the sesquiterpenoid is present in the composition at a concentration of up to 1% w/w.

3. An oral care composition according to claim 1 , wherein the bisabolol has a BEC 50 of 20 ppm to 30 ppm.

4. An oral care composition according to claim 1 , wherein the antimicrobial agent has a BEC 50 in the presence of the sesquiterpenoid of 75% or less compared to the BEC 50 of the antimicrobial agent not in the presence of the sesquiterpenoid.

5. An oral care composition according to claim 4 , wherein the antimicrobial agent has a BEC 50 in the presence of the sesquiterpenoid of 50% or less compared to the BEC 50 of the antimicrobial agent not in the presence of the sesquiterpenoid.

6. An oral care composition according to claim 3 , wherein the Triclosan has a BEC 50 of from 1 ppm to 3 ppm.

7. An oral care composition according to claim 1 , wherein the composition further comprises one or more agents selected from the group consisting of an anti-plaque agent, a whitening agent, a sweetening agent, a cleaning agent and a flavouring agent.

8. An oral care composition according to claim 1 , wherein the composition comprises an orally acceptable carrier for a toothpaste, a dental cream, a mouthwash, a chewing gum or a denture adhesive.

9. A method of inhibiting biofilm formation and/or degrading a biofilm in a subject comprising administering to the subject the composition of claim 1 .

10. The method according to claim 9 , wherein the composition is applied to an oral cavity.

11. The method according to claim 10 , wherein the method prevents or treats a condition caused by biofilm formation in the oral cavity.

12. The method according to claim 11 , wherein the condition is selected from the group consisting of dental plaque, tooth decay, periodontal disease, halitosis, and gingivitis.

13. The method according to claim 9 , wherein the biofilm is formed from a single species of bacteria.

14. The method according to claim 9 , wherein the biofilm is formed from a plurality of species of bacteria.

15. The method according to claim 9 , wherein the biofilm is formed from one or more bacteria selected from the group consisting of A. viscosus, Lactobacillus casei, Streptococcus oxalis, Fusobacterium nucleatum and Veillonella parvula .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2014
From: SCHAEFFER-KORBYLO, LYNDSAY; MORGAN, ANDRE MICHELLE; MIKSA, DAVIDE; DU-THUMM, LAWRENCE; PRENCIPE, MICHAEL
To: COLGATE-PALMOLIVE COMPANY
Reel/Frame 034021/0729 →
Continuity (1)
Related Publication 20120128599A1 · May 24, 2012